Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chia-Chien Lo"'
Autor:
Sze‐Ching Wong, Chun‐Chieh Yeh, Xun‐Yu Zhang, Chih‐Ying Hsieh, Chia‐Chien Lo, Ting‐Ting Kuo, Ching‐Chan Lin, Chih‐Hua Chao, Jing‐Pei Liu, Ling‐Chu Chang, Lu‐Hai Wang, Yuh‐Pyng Sher
Publikováno v:
Molecular Oncology, Vol 17, Iss 8, Pp 1648-1665 (2023)
CUB domain‐containing protein 1 (CDCP1) contributes to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance by regulating EGFR signaling pathways and is a potential target in lung cancer treatment. This study aims to i
Externí odkaz:
https://doaj.org/article/353ae90eeedf4b26a5791f7b425b5f6c
Autor:
Chia-Chien Lo, 羅佳茜
101
The low dose radiation may induce cellular senescence and promote secondary maligancy during radiotherapy. However, the molecular mechanisms are unclear. It has been reported that a variety of early response oncogenes can be up-regulated by
The low dose radiation may induce cellular senescence and promote secondary maligancy during radiotherapy. However, the molecular mechanisms are unclear. It has been reported that a variety of early response oncogenes can be up-regulated by
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/50575683509244812863
Autor:
null Sze‐Ching Wong, null Chun‐Chieh Yeh, null Xun‐Yu Zhang, null Chih‐Ying Hsieh, null Chia‐Chien Lo, null Ting‐Ting Kuo, null Ching‐Chan Lin, null Chih‐Hua Chao, null Jing‐Pei Liu, null Ling‐Chu Chang, null Lu‐Hai Wang, null Yuh‐Pyng Sher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d591f312090081d63a1d707501ebfe9
https://doi.org/10.1002/1878-0261.13429/v2/response1
https://doi.org/10.1002/1878-0261.13429/v2/response1
Autor:
Chia-Chien Lo, Jyh-Der Leu, Yi Jang Lee, Shi-Ting Lin, Bo Shen Wang, Chun-Yuan Chang, Chung-Yih Wang, Wen-Chin Hung, Min-Ying Lin
Publikováno v:
Aging (Albany NY)
Ionizing radiation is known to cause cell apoptosis at high dose range, but little is known about the cellular response to low dose radiation. In this study, we found that conditioned medium harvested from WI-38 lung fibroblasts and H1299 lung adenoc
Autor:
Yu-Kai Huang, Liang-Chuan Lai, Yuh Pyng Sher, Ting Ting Kuo, Shih Ting Bai, Han Shui Hsu, Wei Chao Chang, Chen Yuan Lin, Guan Chin Tseng, Xing Guo Li, Wei-Chung Cheng, Yi Fan Jiang, Chih Ying Hsieh, Chia Chien Lo, Yu Sen Lin
Publikováno v:
International Journal of Biological Sciences
Hypoxia and angiogenesis play key roles in the pathogenesis of esophageal squamous cell carcinoma (ESCC), but regulators linking these two pathways to drive tumor progression remain elusive. Here we provide evidence of ADAM9's novel function in ESCC
Autor:
Wei-Chung Cheng, Yuh Pyng Sher, Chia-Chien Lo, Guan-Chin Tseng, Yu-Kai Huang, Ching Chan Lin, Jin-Yuan Shih, Ting-Ting Kuo, K. S. Clifford Chao, Jennifer L. Hsu, Tzu-Hung Hsiao, Liang-Chuan Lai, Xian Sun, Mien Chie Hung, Chia-Fong Cho, Pei-Chih Lee, Yu-Huei Liu, Yu Sen Lin, Wei Chao Chang
Publikováno v:
Theranostics
Rationale: Brain metastasis in patients with lung cancer is life-threatening. However, the molecular mechanism for this catastrophic disease remains elusive, and few druggable targets are available. Therefore, this study aimed to identify and charact
Autor:
Ching-Heng Lin, Chia Chien Lo, Chih Ying Hsieh, Yuh Pyng Sher, Cheng Wei Chou, Cheng Chung Huang, Tzu Hung Hsiao
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Scientific Reports
The p53 gene is an important tumour suppressor gene. Mutant p53 genes account for about half of all lung cancer cases. There is increasing evidence for the anti-tumour effects of statins via inhibition of the mevalonate pathway. We retrospectively in
Autor:
K. S. Clifford Chao, Guan-Chin Tseng, Chun-Yu Chang, Sze-Ching Wong, Shu-Fen Chiang, Liang-Chuan Lai, Tzu-Pin Lu, Chia-Chien Lo, Yuh Pyng Sher, Wei-Chung Cheng, Kevin Chih-Yang Huang, Chih-Ying Hsieh, Ting-Ting Kuo
Publikováno v:
Theranostics
Rationale: Lung adenocarcinoma (LUAD) is an aggressive disease with high propensity of metastasis. Among patients with early-stage disease, more than 30% of them may relapse or develop metastasis. There is an unmet medical need to stratify patients w
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
Autor:
Yu Sen Lin, Chia Chien Lo, Hsien Fang Chang, Wei-Chung Cheng, Yen Nien Liu, Yuh Pyng Sher, Eric Y. Chuang, Kuo Liang Chiu, Ting Ting Kuo, Yu-Kai Huang, Ching Chan Lin, Liang-Chuan Lai
Publikováno v:
Oncotarget
// Kuo-Liang Chiu 1, 4, 5, * , Yu-Sen Lin 1, 8, * , Ting-Ting Kuo 7 , Chia-Chien Lo 7 , Yu-Kai Huang 7 , Hsien-Fang Chang 6 , Eric Y. Chuang 6 , Ching-Chan Lin 1, 9 , Wei-Chung Cheng 2, 3 , Yen-Nien Liu 10 , Liang-Chuan Lai 6, 11 and Yuh-Pyng Sher 1,
Autor:
Wei-Chung Cheng, Chun-Yu Chang, Chia-Chien Lo, Chih-Ying Hsieh, Ting-Ting Kuo, Guan-Chin Tseng, Sze-Ching Wong, Shu-Fen Chiang, Chih-Yang Huang, Kevin, Liang-Chuan Lai, Tzu-Pin Lu, Chao, K. S. Clifford, Yuh-Pyng Sher
Publikováno v:
Theranostics; 2021, Vol. 11 Issue 8, p3661-3675, 15p